CGRP blockade and cluster headache: another step forward
- PMID: 40252653
- DOI: 10.1016/S1474-4422(25)00103-6
CGRP blockade and cluster headache: another step forward
Conflict of interest statement
I declare being an advisory board member for Allergan/Abbvie, Aralez/Tribute/Miravo Pharmaceuticals, Eli Lilly, Lundbeck, Teva Neurosciences, and Novartis; consultancy for Allergan/Abbvie, Eli Lilly, Kye Pharmacueticals, LinPharma, Organon, Paladin, Pfizer Canada, Teva Neurosciences, and Novartis; and being a speaker for Allergan/Abbvie, Aralez/Tribute/Miravo Pharmaceuticals, Eli Lilly, Lundbeck, Pfizer Canda, Teva Neurosciences, and Novartis.
LinkOut - more resources
Full Text Sources
Research Materials
